ERLOTINIB MESYLATE
- Product NameERLOTINIB MESYLATE
- CAS248594-19-6
- CBNumberCB7677124
- MFC23H27N3O7S
- MW489.54
- MDL NumberMFCD08272810
- MOL File248594-19-6.mol
- MSDS FileSDS
Chemical Properties
| storage temp. | Store at -20°C |
| solubility | 25℃: DMSO |
| form | Powder |
ERLOTINIB MESYLATE Price
| Product number | Packaging | Price | Product description | Buy |
|---|---|---|---|---|
| Biosynth FE65018 | 50mg | $182.5 | Erlotinib mesylate |
Buy |
| Biosynth FE65018 | 100mg | $289 | Erlotinib mesylate |
Buy |
| Biosynth FE65018 | 250mg | $527.5 | Erlotinib mesylate |
Buy |
| Biosynth FE65018 | 500mg | $860 | Erlotinib mesylate |
Buy |
| Biosynth FE65018 | 1000mg | $1540 | Erlotinib mesylate |
Buy |
ERLOTINIB MESYLATE Chemical Properties,Usage,Production
Uses
Erlotinib mesylate (CP-358774 mesylate) inhibits purified EGFR kinase with an IC50 of 2 nM. Erlotinib (mesylate) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.in vivo
There is a 1.49-fold statistically significant difference between AUC0-inf after p.o. administration of Erlotinib (5 mg/kg) comparing Bcrp1/Mdr1a/1b-/- and WT mice (7,419±1,720 versus 4,957±1,735 ng*h/mL respectively, P=0.01)[3]. The administration of Erlotinib (10 mg/kg/day, or 20 mg/kg/day) to Bleomycin (BLM)-treated rats shows no exacerbation of lung injuries in indices such as macroscopic findings, lung weights, histopathological scores (lung lesion density and lung fibrosis score), and pulmonary hydroxyproline (HyP) level. The result suggests that Erlotinib does not have any exacerbating effects on lung injuries induced by BLM in rats[4].
IC 50
EGFR: 2 nM (IC50)References
[1] Moyer JD, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 1997 Nov 1;57(21):4838-48. PMID:9354447[2] Ali S, et al. Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol Cancer Ther, 2008, 7(6), 1708-1719. DOI:10.1158/1535-7163.MCT-08-0354
[3] Marchetti S, et al. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.Mol Cancer Ther. 2008 Aug;7(8):2280-7. DOI:10.1158/1535-7163.MCT-07-2250
[4] Adachi K, et al. Effects of erlotinib on lung injury induced by intratracheal administration of bleomycin (BLM) in rats. J Toxicol Sci. 2010 Aug;35(4):503-14. DOI:10.2131/jts.35.503
Preparation Products And Raw materials
ERLOTINIB MESYLATE Supplier
Global(37)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +1 (866) 930-6790 | info@adooq.com | United States | 2773 | 58 | |
| 0523-86818997 18652728585 |
sales@allyrise.com | China | 2991 | 60 | |
| 027-87465837 19945049750 |
sales@finetechnology-ind.com | China | 9259 | 58 | |
| 0755-89396905 | admin@nexconn.com | China | 299 | 55 | |
| 025-58849295 | info@adooq.cn | China | 2980 | 60 | |
| 21-619849051-1 18521059765 |
synchempharma@aliyun.com | China | 4987 | 55 | |
| 571-89925085 | sales@amadischem.com | China | 131884 | 58 | |
| +1-800-259-7612 | info@musechem.com | United States | 4647 | 60 | |
| 021-58111628 15800915896 |
sales@twochem.com | China | 1782 | 58 | |
| 18081075745 | chemflowtech@sina.com | China | 1883 | 58 |
248594-19-6, ERLOTINIB MESYLATERelated Search
- Erlotinib
- DesMethyl Erlotinib Carboxylate Acid
- 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
- Erlotinib D6 HCl
- Erlotinib iMpurity 2
- Erlotinib Impurity Q
- Erlotinib
- 6-O-DesMethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride
- Erlotinib iMpurity
- Desmethyl Erlotinib Acetate
1of4
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine